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OBJECTIVE: Pneumoperitoneum during laparoscopy results in transient oliguria and decreased glomerular
filtration and renal blood flow. The presence of oliguria and elevated serum creatinine is suggestive of acute
renal injury. Serum cystatin C has been described as a new marker for the detection of this type of injury. In this
study, our aim was to compare the glomerular filtration rate estimated using cystatin C levels with the rate
estimated using serum creatinine in patients with normal renal function who were undergoing laparoscopic
surgery.
METHODS: In total, 41 patients undergoing laparoscopic cholecystectomy or hiatoplasty were recruited for the
study. Blood samples were collected at three time intervals: first, before intubation (T1); second, 30 minutes
after the establishment of pneumoperitoneum (T2); and third, 30 minutes after deflation of the
pneumoperitoneum (T3). These blood samples were then analyzed for serum cystatin C, creatinine, and
vasopressin. The Larsson formula was used to calculate the glomerular filtration rate based on the serum
cystatin C levels, and the Cockcroft-Gault formula was used to calculate the glomerular filtration rate according
to the serum creatinine levels.
RESULTS: Serum cystatin C levels increased during the study (T1 = T2,T3; p,0.05), whereas serum creatinine
levels decreased (T1=T2.T3; p,0.05). The calculated eGlomerular filtration rate-Larsson decreased, whereas
the eGlomerular filtration rate-Cockcroft-Gault increased. There was no correlation between cystatin C and
serum creatinine. Additionally, Pearson’s analysis showed a better correlation between serum cystatin C and the
eGlomerular filtration rate than between serum creatinine and the eGlomerular filtration rate.
CONCLUSION: This study demonstrates that serum cystatin C is a more sensitive indicator of changes in the
glomerular filtration rate than serum creatinine is in patients with normal renal function who are undergoing
laparoscopic procedures.
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& INTRODUCTION
The role of laparoscopic surgery has expanded in recent
years. This technique’s minimally invasive approach for
complex surgeries and shorter recovery time have popular-
ized its use. One of the primary requirements for laparoscopic
surgery is the establishment of pneumoperitoneum by the
insufflation of carbon dioxide into the abdomen to allow
visualization of the abdominal structures. Pneumoperitoneum
is a non-physiologic condition that causes a higher intra-
abdominal pressure compared with what is present normally.
This higher pressure is transmitted to the abdominal organs,
including the kidneys. An intra-abdominal pressure higher
than 10 mm Hg has been shown to produce transient oliguria
and to decrease the glomerular filtration rate (GFR) and renal
blood flow (RBF) (1-9).
Renal dysfunction can be detected early using renal
function tests. The diagnosis of acute renal injury is based
on the elevation of serum creatinine, the presence of oliguria
(10), or both. However, a substantial increase in serum
creatinine does not occur until 48-72 hours after an initial
insult. The serum creatinine concentration can also be
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affected by other factors, such as gender, diet, exercise,
hydration, and muscle mass (11).
Recently, a new marker has been described for detecting
renal dysfunction (12-15): serum cystatin C (Cys C). Cys C is
a protein produced at a constant rate by all nucleated cells.
This protein is cleared by the glomeruli, reabsorbed by the
renal tubules and metabolized; thus, it is not returned to
the circulation (16-18). To our knowledge, no reports in the
literature have compared Cys C and creatinine levels as
markers of renal dysfunction in patients undergoing
laparoscopic surgery. The goal of the present study was to
compare the GFRs calculated using the serum levels of Cys
C and creatinine as markers for possible early detection of
renal dysfunction in patients undergoing laparoscopic
surgery.
& METHODS
This study was approved by the Research and Ethics
Committee of Botucatu Medical School. In total, 41 patients
between the ages of 18 and 55 years and undergoing elective
laparoscopic cholecystectomy or hiatoplasty were recruited
for the study. All patients were ASA (risk index classifica-
tion of the American Society of Anesthesiology) Class I or II
and had a body mass index below 30 kg/m2 and provided
informed consent. All subjects had normal renal function, as
determined by normal preoperative creatinine levels.
Patients with thyroid abnormalities, impaired renal func-
tion, uncontrolled hypertension, or diabetes mellitus were
excluded. Patients with a history of using anti-inflammatory
drugs, alcohol, or illicit substances were also excluded.
None of the patients underwent bowel preparation prior to
surgery, and all subjects were NPO for 8 hours before
surgery.
The patients were monitored with standard ASA moni-
tors. An intravenous catheter was placed, and a bolus of
Ringer’s lactate 10 mL.kg-1 was administered prior to the
induction of anesthesia. Additionally, all subjects were
preoxygenated. Anesthesia was induced with an intrave-
nous injection of propofol 2-3 mg.kg-1 and remifentanil
0.5 mg.kg-1 over 5 minutes. Tracheal intubation with direct
laryngoscopy was accomplished after adequate muscle
relaxation following the administration of rocuronium
0.6 mg.kg-1. Anesthesia was then maintained using a
continuous infusion of propofol 150-250 mg.kg-1min-1, which
was titrated to maintain a bispectral index (BIS) of 50-60.
Remifentanil was also infused at a rate of 0.1-0.3 mg.kg-1min-1.
Additional doses of rocuronium were given to maintain
muscle relaxation. Moreover, a semi-closed anesthesia
system with controlled ventilation was used to maintain the
Pet CO2 at 35-40 mm Hg.
Lactated Ringer’s solution was infused at a rate of
10 mL.kg-1hr-1 for the duration of the surgery. An abdom-
inal cannula was placed and carbon dioxide was insufflated
into the abdomen. The intra-abdominal pressure was
maintained at 15 mm Hg. At the conclusion of surgery,
propofol and remifentanil infusion was discontinued. A
Foley catheter was not placed because of the brevity of the
procedure and the potential for urinary tract infection
postoperatively. The neuromuscular blockade was reversed
with atropine and neostigmine based on each subject’s
weight. Subjects were extubated when the train-of-four ratio
was 1 and they resumed spontaneous ventilation, were able
to follow commands, and could sustain a 5-second head lift.
Each patient’s electrocardiogram, heart rate, blood pres-
sure, temperature, oxygen saturation, and end-tidal carbon
dioxide were monitored throughout the surgery. In addi-
tion, the intra-abdominal pressure was monitored and
maintained at 15 mm Hg.
Each patient’s heart rate, blood pressure, and BIS were
recorded at 9 different times: (T0) before the induction of
anesthesia; (T1) after the induction of anesthesia but before
tracheal intubation; (T2) 5 minutes after tracheal intubation;
(T3) immediately after abdominal insufflation; (T4-T6) 15,
30, and 45 minutes after insufflation; and (T7-T8) immedi-
ately and 30 minutes after deflation.
Blood samples were collected at three different times:
(T1) The first sample was collected before intubation.
(T2) The second sample was collected 30 minutes after
the insufflation of carbon dioxide and the creation of the
pneumoperitoneum.
(T3) The third sample was collected 30 minutes after
deflation of the pneumoperitoneum.
These blood samples were analyzed for the serum levels
of Cys C, creatinine and vasopressin at the three time
periods listed.
Serum Cys C was measured by nephelometric immu-
noassay using the Behring system (BN-II, Dade Behring,
Marburg, Germany) (19). The modified Jaffe reaction was
performed on a Beckman Coulter LX20 Pro Clinical system
(Beckman Coulter Inc., Brea, CA, USA) with the recom-
mended reagents to measure serum creatinine. Vasopressin
was measured by a specific radioimmunoassay after
extraction from the plasma using acetone and ether (20).
Renal function was determined by calculation of the GFR.
The Larsson formula (eGFR-Larsson = 77.24 X Cys C
mL.L-1)-1.2623 (21) was used to calculate the GFR using the
serum Cys C levels. The Cockcroft-Gault (CG) formula
(eGFR-CG = ([(140-age) x weight (kg)]/(plasma creatinine x
72)) (0.85 in the case of a female patient)) was also used (22).
Statistical Analysis
An analysis was performed prior to the study to
determine the number of subjects required to detect a mean
difference between the time points of 0.2, in association with
a standard deviation of 0.2 with 80% power and an error
less than 0.05. It was determined that 30 subjects needed to
be enrolled in the study based on the biological viability of
serum Cys C. Serum vasopressin levels were later analyzed
using the Friedman test. Additionally, the Pearson correla-
tion coefficient test was used to evaluate the correlation
between the biomarkers and the GFR. Throughout the
study, p values ,0.05 were considered significant. Prism
software (version 4.0, GraphPad software, La Jolla, CA,
USA) was used to perform the statistical analysis.
& RESULTS
In total, 41 patients completed the study, of whom 29%
were male and 71% were female. Additionally, 78% under-
went cholecystectomy, and 22% underwent hiatoplasty. The
biometric data and durations of anesthesia and pneumoper-
itoneum are summarized in Table 1.
Hemodynamic changes are shown in Figure 1. Heart rate
and blood pressure decreased with the induction of
anesthesia but returned to baseline 30 minutes after
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abdominal deflation. There was then an increase in heart
rate and blood pressure fifteen minutes after the insufflation
of carbon dioxide, and this increase was statistically
significant. There was also a statistically significant increase
in end-tidal CO2 after the insufflation of carbon dioxide. In
contrast, vasopressin levels did not change at any time
point, as shown in Figure 2.
Baseline renal function was normal in all subjects. There
was a significant increase in Cys C levels 30 minutes after
deflation of the abdomen (Figure 3) (p,0.001). As a result,
the eGFR calculated by the Larsson formula was also lower
during that time period (Figure 5) (p,0.02). Serum
creatinine was lower 30 minutes after deflation of the
abdomen, so the eGFR calculated using the CG formula
showed a significant increase compared with baseline
(Figures 4-5) (p,0.002). A comparison of these two methods
of GFR calculation suggested that Cys C was more sensitive
for the detection of mild to moderate changes in renal
function in patients undergoing laparoscopic procedures.
Pearson’s analysis showed a better correlation between
Cys C and eGFR-Larsson than between Creatinine and
eGFR-CG (Table 2). Additionally, there was no significant
correlation between Cys C and serum creatinine values
(p.0.05).
Our results indicate that serum Cys C and the eGFR
derived from it perform better as an early marker of changes
in renal function compared with serum creatinine and its
derived eGFR in patients with normal renal function who
are undergoing laparoscopic surgery.
& DISCUSSION
Oliguria that is dependent on the intra-abdominal pressure
is observed during laparoscopy following pneumoperitoneum
Table 1 - Biometric data and the duration of anesthesia and pneumoperitoneum. The data are presented as the mean¡
standard deviation. The range of the variables is also included in the table.
Variable Mean ¡ standard deviation (range)
Age (years) 34.9¡8.9 (17-53)
Height (cm) 165.0¡14.3 (150-192)
Weight (kg) 69.3¡9.7 (46-101)
BMI* (kg/m2) 25.4¡4.4 (18.0-29.9)
Duration of anesthesia (min) 146.5¡41.5 (80-240)
Duration of pneumoperitoneum (min) 84.2¡37.7 (40-185)
*Body mass index.
Figure 1 - Heart rate and systolic blood pressure (mean ¡
standard deviation) at baseline and at the different time points
in the study. (T0) before anesthesia induction; (T1) after
induction and before tracheal intubation; (T2) 5 minutes after
tracheal intubation; (T3) immediately after abdominal insuffla-
tion; (T4-T6) 15, 30, and 45 minutes after abdominal insufflation;
(T7-T8) immediately after and 30 minutes after abdominal
deflation. *p,0.05 versus baseline values.
Figure 2 - Vasopressin levels (mean ¡ standard deviation) at
baseline (T1), 30 minutes after abdominal insufflation (T2), and
30 minutes after the end of the pneumoperitoneum (T3).
Figure 3 - Cystatin C in mg.L-1 (mean ¡ standard deviation) at
baseline (T1), 30 minutes after abdominal insufflation (T2), and
30 minutes after the end of the pneumoperitoneum (T3).
*p,0.05 versus baseline values.
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(1,23). Several mechanisms, including renal vein compression,
renal parenchyma compression, and hormonal effects, are
implicated in the development of oliguria (1-9). For example,
Hartman et al. have shown that cardiac output decreases
during laparoscopy, although normalizing cardiac output
does not improve the GFR or RBF (8). Moreover, a recent study
has shown that if an intra-abdominal pressure greater than
20 mm Hg is maintained for longer than 2 hours, it produces
tubular damage and histologic changes in the subcapsular
renal cortex (4).
Special attention must be paid to urine output and the
GFR during the preoperative management of patients with
decreased renal function who will undergo laparoscopic
procedures. The early detection of renal dysfunction in
these patients may allow better protection of the kidneys
against further damage or further deterioration of function.
The present prospective clinical trial was performed to
determine the effectiveness of serum Cys C as a marker of
renal dysfunction compared with serum creatinine. Subjects
undergoing laparoscopic procedures were recruited for the
study because these patients experience a transitory increase
in intra-abdominal pressure due to the insufflation of CO2,
which can decrease renal function.
Several biomarkers and laboratory tests can be used to
assess the GFR and tubular function (24,25). Although
widely used, changes in serum creatinine are not specific;
they do not indicate the nature of the insult and are
relatively insensitive to mild changes in the GFR (10,11,26).
The current study confirms these findings. The GFR
estimated based on serum creatinine did not detect mild
changes in renal function, whereas serum Cys C levels were
sensitive and reflected renal changes. In particular, there
was a 4% increase in serum Cys C levels and eGFR-Larsson
was 4% lower than at baseline 30 minutes after pneumoper-
itoneum creation (T2), with a pressure of 15 mm Hg. Thirty
minutes after deflation of the abdomen (T3), serum Cys C
was 9% higher, and the eGFR-Larsson was 10% lower,
indicating that the kidneys required time to recover from
the insult. In an experimental model, McDougall et al.
demonstrated that when an intra-abdominal pressure of
15 mm Hg or more was sustained for more than 2 hours,
there was a significant decrease in blood flow in the renal
vein and a decrease in creatinine clearance (3). A clinical
study of 40 patients undergoing colorectal surgery with
laparoscopy confirmed the previous result and also showed
compromised creatinine clearance 2 hours after pneumo-
peritoneum deflation (27).
In our study, there were unexpected decreases in serum
creatinine levels of 4% and 9% at T2 and T3, respectively. In
contrast, the eGFR-CG showed increases of 6% and 17% at
T2 and T3, respectively. The most likely explanation for the
lower creatinine levels at this time is hemodilution
secondary to aggressive volume replacement, overlapping
with a decrease in renal function. Chang et al., reported
similar results regarding the decrease in serum creatinine
levels after laparoscopic surgery, despite the presence of
oliguria (23). These authors also concluded that a high rate
of intravenous hydration was the cause of this decrease in
serum creatinine.
The ideal biomarker for detecting renal injury should
have several qualities (28-29). It should be endogenous,
nontoxic, freely filtered by the glomeruli, and excreted
unchanged by the kidneys. It must also be readily available
for use in clinical practice, and the measurement of such a
biomarker should be easy, rapid, and inexpensive. In
addition, the biomarker’s measurement should be an
accurate and reliable surrogate for the GFR. Such a test
should detect renal injury in a population with different
renal pathologies. Moreover, the test should be sensitive
Figure 5 - The glomerular filtration rate calculated using Larsson’s formula (mean¡ standard deviation) and the glomerular filtration
rate calculated using the Cockcroft-Gault formula (mean ¡ standard deviation) at baseline (T1), 30 minutes after abdominal
insufflation (T2), and 30 minutes after the end of the pneumoperitoneum (T3). *p,0.05 versus baseline values.
Figure 4 - Creatinine in mg.dL-1 (mean ¡ standard deviation) at
baseline (T1), 30 minutes after abdominal insufflation (T2), and
30 minutes after abdominal deflation (T3). *p,0.05 versus
baseline values.
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and specific for identifying small changes in renal function
and detecting early injury.
A biomarker that can reflect real-time dynamic changes in
the GFR is not available at present for clinical use. The
serum creatinine concentration is influenced by extrarenal
factors such as muscle mass, diet, gender and exercise (11).
Creatinine takes time to accumulate before abnormal levels
are detected, which can potentially delay the diagnosis of
acute changes in the GFR. In fact, several studies have
shown that serum Cys C levels are more sensitive for
detecting early and mild changes in renal function com-
pared with the sensitivity of serum creatinine levels (30-32).
Additionally, the studies showed that Cys C levels are not
affected by extrarenal factors. Recent studies, however, have
shown that gender, C-reactive protein levels, height, weight,
diabetes, the use of corticosteroids, abnormal thyroid
function, and the presence of systemic inflammation can
affect serum Cys C levels (33-35). We minimized the
influence of these factors in the present study, as subjects
with thyroid dysfunction, diabetes mellitus, or high body
mass index were excluded. We also excluded patients who
were taking steroids or anti-inflammatory drugs.
We are aware that our study clearly has certain limita-
tions. First, no biomarker will ever be able to satisfy all of
the criteria for an ideal marker. More importantly, no single
biomarker will be able to accurately estimate the GFR and
indicate the nature of a renal injury at the same time.
However, this study shows that, although far from being
ideal, Cys C may be more sensitive than creatinine in the
detection of the early stages of renal dysfunction. Second,
the equations used to estimate the GFR were developed for
GFR estimation in healthy patients. Hence, the results
cannot be extrapolated to patients with renal impairment.
Further studies need to be performed to evaluate the clinical
utility of Cys C and these formulae in estimating the GFR in
patients with renal impairment who are undergoing
laparoscopic procedures.
In conclusion, Cys C is a more sensitive biomarker for the
detection of early impairment of the GFR during laparo-
scopic surgery in patients with normal renal function.
Further studies are necessary to determine whether Cys C is
also an appropriate biomarker for the identification of renal
dysfunction in patients with renal disease who are likely to
undergo laparoscopic procedures.
Source of support: Brazilian Federal Agency for the
Support and Evaluation of Graduate Education (CAPES).
& IMPLICATIONS STATEMENT
The present study demonstrated that cystatin C was more
efficient than serum Cr in the detection of early changes in
the estimated GFR during laparoscopic surgery in patients
with previously normal renal function.
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